Next Article in Journal
Molecular Alterations in TP53, WNT, PI3K, TGF-Beta, and RTK/RAS Pathways in Gastric Cancer Among Ethnically Heterogeneous Cohorts
Previous Article in Journal
New Concept of Colonoscopy Assisted by a Microwave-Based Accessory Device: First Clinical Experience
 
 
Systematic Review
Peer-Review Record

Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic Strategy

Cancers 2025, 17(7), 1074; https://doi.org/10.3390/cancers17071074
by Daniela Sambataro 1,2,*, Sandro Bellavia 3, Paolo Di Mattia 2,4, Danilo Centonze 4, Carmela Emmanuele 3, Annalisa Bonasera 1, Giuseppe Caputo 1, Andrea Maria Onofrio Quattrocchi 1, Ernesto Vinci 1, Vittorio Gebbia 2 and Maria Rosaria Valerio 5
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3:
Cancers 2025, 17(7), 1074; https://doi.org/10.3390/cancers17071074
Submission received: 19 February 2025 / Revised: 11 March 2025 / Accepted: 19 March 2025 / Published: 22 March 2025
(This article belongs to the Section Cancer Causes, Screening and Diagnosis)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

The article describes and systematically revises the case reports concerning this rare diseases. The authors should be commended for gathering such amount of information.

THe authors stated that the median overall survival was 10 months. How did they calculate this outcome? Just taking a look at Table 1, median overall survival doesn't seem 10 months....

The authors should comment more in the discussion about the impact of NEN on the liver (cite the series PMID: 27956320)

Which systemic therapies could be used in this kind of mixed neoplasia? COmment on the rationale to the current evidence

Author Response

For research article

 

Response to Reviewer X Comments

 

1. Summary

 

 

Thank you very much for taking the time to review this manuscript. Please find the detailed responses below and the corresponding revisions/corrections highlighted/in track changes in the re-submitted files

 

2. Questions for General Evaluation

Reviewer’s Evaluation

Response and Revisions

Does the introduction provide sufficient background and include all relevant references?

Can be improved

We implemented the introduction as required by the Referees

 

Are all the cited references relevant to the research?

Yes

 

Is the research design appropriate?

Yes

 

Are the methods adequately described?

Yes

 

Are the results clearly presented?

Yes

 

Are the conclusions supported by the results?

 

Yes

 

3. Point-by-point response to Comments and Suggestions for Authors

1.       Comments 1: The article describes and systematically revises the case reports concerning this rare diseases. The authors should be commended for gathering such amount of information.

Response 1: Thank you very much for taking the time to review this manuscript and for this appreciation

 

1.       Comments 2: The authors stated that the median overall survival was 10 months. How did they calculate this outcome? Just taking a look at Table 1, median overall survival doesn't seem 10 months...

 

Response 2: We used a statistical software for calculations, repeated them and the median is 10 months.

1.       Comment 3: the authors should comment more in the discussion about the impact of NEN on the liver (cite the series PMID: 27956320)

Response 3: We added in the discussion a paragraph with a brief description about the treatment and cited the suggested article.

 

1.       Comment 4: Which systemic therapies could be used in this kind of mixed neoplasia? Comment on the rationale to the current evidence.

Response 4: We added in the discussion a paragraph about the treatments with the best survival found in published cases and suggested a treatment hypothesis such as the combination of atezolizumab bevacizumab, standard treatment for advanced hepatocarcinoma, with the rationale that suggested this hypothesis to us.

 

4. Response to Comments on the Quality of English Language

Point 1: The English is fine and does not require any improvement.

 

Response 1:

5. Additional clarifications

none

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

Cancers (Manuscript ID: cancers-3492406), Comments to the Authors:

 

Title: Combined neuroendocrine carcinoma and hepatocellular carcinoma of the liver: Systematic literature review

 

Comments

The submitted review highlighted cases of primary mixed HCC and NEC in the liver. The search adhered to PRISMA guidelines, and relevant studies were critically analyzed. A total of 45 documented cases were reviewed, focusing on patient demographics, clinical characteristics, treatment strategies, and outcomes. Most patients (90%) were male, with a median age of 66.5 years. Hepatitis B or C infection was present in 74% of cases, and liver cirrhosis was reported in 38%. The combined type was the most frequently observed histological pattern (65%). Treatment modalities varied, including transarterial chemoembolization (TACE), radiofrequency ablation (RFA), surgery, and systemic therapies. The median overall survival was 10 months, highlighting the aggressive nature of these tumors.

 

I think the submitted review can be accepted after the authors respond to the following comments: 

  1. The title is confusing, the authors should rephrase the title to provide more information about the work in the submitted paper.
  2. There are no graphs in the submitted review. The authors may try to summarize their findings in an illustrative figure.
  3. By reviewing table 1, I found many missing data points that will definitely affect the results obtained by the authors. How did the authors handle this issue.
  4. The methods lack detail on statistical approaches, particularly for handling censored survival data. Can the authors comment on this issue?
  5. Heterogeneity was very common in many cases in terms of demographics, treatments, and outcomes. How did the authors handled this issue and did it affect the conclusion.
  6. The authors should include “limitations” subsection in their review.
  7. The authors should expand the discussion on molecular mechanisms and therapeutic prospects beyond general statements.
Comments on the Quality of English Language

The English quality is fine. 

Author Response

For research article

 

 

Response to Reviewer X Comments

 

1. Summary

 

 

Thank you very much for taking the time to review this manuscript. Please find the detailed responses below and the corresponding revisions/corrections highlighted/in track changes in the re-submitted files.

 

2. Questions for General Evaluation

Reviewer’s Evaluation

Response and Revisions

Does the introduction provide sufficient background and include all relevant references?

Can be improved

we improved the introduction

 

Are all the cited references relevant to the research?

 

Can be improved

 

We believe the references cited are necessary

 

Is the research design appropriate?

Can be improved

we improved the research design with all the suggestions received from the reviewers

 

Are the methods adequately described?

Can be improved

we improved the description of methods

 

Are the results clearly presented?

Can be improved

we improved the results with figures

 

Are the conclusions supported by the results?

Can be improved

we modified the conclusion

 

3. Point-by-point response to Comments and Suggestions for Authors

  1. Comments 1: The title is confusing, the authors should rephrase the title to provide more information about the work in the submitted paper.

 

Response 1: Thank you for pointing this out. We agree with this comment. Therefore, we have changed the title: “COMBINED NEUROENDOCRINE CARCINOMA AND HEPATOCELLULAR CARCINOMA OF THE LIVER: SYSTEMATIC LITERATURE REVIEW SUGGESTS IMPLEMENTING BIOLOGICAL CHARACTERIZATION TO OPTIMIZE THERAPEUTIC STRATEGY”.

  1. Comments 2: There are no graphs in the submitted review. The authors may try to summarize their findings in an illustrative figure.

 

Response 2: Agree. We have add illustrative figures of results    

 

  1. Comment 3: By reviewing table 1, I found many missing data points that will definitely affect the results obtained by the authors. How did the authors handle this issue.

Response 3: Data missing from the table were not shown in the individual reports. The analyses reported are only percentages and medians that refer to cases where the data was present.

 

1.       Comment 4: The methods lack detail on statistical approaches, particularly for handling censored survival data. Can the authors comment on this issue?

Response 4: We added in the materials and methods, For the description of results, we used percentages and medians with range using only known data.

 

  1. Comment 5: Heterogeneity was very common in many cases in terms of demographics, treatments, and outcomes. How did the authors handled this issue and did it affect the conclusion.

Response 5: There is considerable heterogeneity in the reported data, which mainly relates to treatment modalities, so we limited ourselves to case descriptions, and medians were reported in the table along with the number of cases where survival was reported.

 

1.       Comment 6: The authors should include “limitations” subsection in their review.

Response 6: In the “conclusions section” we added that the reported results have limitations: There is considerable variability in the reported data in terms of demographics, treatments, and outcomes, the latter probably related to the heterogeneity of clinical characteristics and treatment modalities.

 

1.       Comment 7: The authors should expand the discussion on molecular mechanisms and therapeutic prospects beyond general statements.

     Response 7: in the discussion we have reported a further paragraph concerning     treatment.

 

 

4. Response to Comments on the Quality of English Language

Point 1: The English could be improved to more clearly express the research.

Response 1: we improved the English  

5. Additional clarifications

none

 

Author Response File: Author Response.pdf

Reviewer 3 Report

Comments and Suggestions for Authors

The authors present a research paper based on previous studies on the combined cancers in liver and draw the conclusions. But i dont find any new data being generated nor are there any strong conclusions drawn from this study. I would suggest the authors to convert it into a review and present some future perspective in this area. 

Author Response

For research article

 

 

Response to Reviewer X Comments

 

1. Summary

 

 

Thank you very much for taking the time to review this manuscript. Please find the detailed responses below and the corresponding revisions/corrections highlighted/in track changes in the re-submitted files. [This is only a recommended summary. Please feel free to adjust it. We do suggest maintaining a neutral tone and thanking the reviewers for their contribution although the comments may be negative or off-target. If you disagree with the reviewer's comments please include any concerns you may have in the letter to the Academic Editor.]

 

2. Questions for General Evaluation

Reviewer’s Evaluation

Response and Revisions

Does the introduction provide sufficient background and include all relevant references?

Yes

 

Are all the cited references relevant to the research?

Yes

 

Is the research design appropriate?

Yes

 

Are the methods adequately described?

Yes

 

Are the results clearly presented?

Yes

 

Are the conclusions supported by the results?

Yes

 

 

3. Point-by-point response to Comments and Suggestions for Authors

 

Comments 1: The authors present a research paper based on previous studies on the combined cancers in liver and draw the conclusions. But i dont find any new data being generated nor are there any strong conclusions drawn from this study. I would suggest the authors to convert it into a review and present some future perspective in this area

 

Response 1: We have modified and added some paragraphs regarding the possible conclusions in this literature review that concerns only a few cases. The discussion and conclusions have been modified to be able to underline the evidence that can be useful and applicable in the future and that concern the need for a better biological definition with the implementation of liver biopsies and a therapeutic suggestion, with relative rationale, that is reported in a literature case.

 

 

4. Response to Comments on the Quality of English Language

Point 1: The English is fine and does not require any improvement.

 

5. Additional clarifications

None

 

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

Comments and Suggestions for Authors

The manuscript is OK

Reviewer 2 Report

Comments and Suggestions for Authors

Cancers (Manuscript ID: cancers-3492406), Comments to the Authors:

 

Title: Combined neuroendocrine carcinoma and hepatocellular carcinoma of the liver: Systematic literature review

 

Comments

After reading the authors response to my comments, I think the revised manuscript can be accepted for publication.   

Comments on the Quality of English Language

The English language of the paper is fine. 

Reviewer 3 Report

Comments and Suggestions for Authors

accept the revised manuscript

Back to TopTop